NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV [Internet]. Washington (DC): Pan American Health Organization; 2020 Apr.

ACKNOWLEDGMENTS

Guideline Development Group

The following individuals contributed to developing this guideline:

John Baddley (Department of Medicine, Division of Infectious Diseases, University of Maryland School of Medicine, Baltimore, Maryland, USA), Mathieu Nacher (Centre d’Investigation Clinique, CIC INSERM 1424, Centre Hospitalier de Cayenne, Cayenne, French Guiana), Alessandro C. Pasqualotto (Universidade Federal de Ciências da Saúde de Porto Alegre and Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Brazil), Ana Belen Arauz (Hospital Santo Tomas, Panama City, Panama), Antoine Adenis (Centre d’Investigation Clinique, CIC INSERM 1424, Centre Hospitalier de Cayenne, Cayenne, French Guiana), Beatriz L. Gomez (School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia), Cristina Elena Canteros (Mycology Department, INEI, ANLIS “Dr. Carlos G. Malbrán,” Buenos Aires, Argentina), Eduardo Arathoon (Asociación de Salud Integral, Guatemala City, Guatemala), Flavio Queiroz Telles (Departamento de Saúde Coletiva, Universidade Federal do Paraná, Curitiba, Brazil), Nataly Garcia (Departamento de Microbiología, Referlab, Caracas, Bolivarian Republic of Venezuela), Tom Chiller (Mycotic Diseases Branch, United States Centers for Disease Control and Prevention, Atlanta, GA, USA).

External Review Group

Alexandro Bonifaz (Hospital General de México, “Dr. Eduardo Liceaga”, Mexico City, Mexico), Ana Alastruey (Servicio de Micología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain), Angela Tobon (Instituto Colombiano de Medicina Tropical, Medellín, Colombia), Arnaldo Colombo (Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil), Blanca Samayoa (Asociación de Salud Integral, Guatemala City, Guatemala), Carol Kauffman (Division of Infectious Diseases, University of Michigan, Ann Arbor, MI, USA), Juan Luis Rodriguez-Tudela (Global Action Fund for Fungal Infections, Geneva, Switzerland), Mohamed Chakroun (Infectious Diseases Department, University Hospital of Monastir, Monastir, Tunisia), Nathan Bahr (University of Kansas, Kansas City, KS, USA), Nelesh P. Govender (National Institute for Communicable Diseases, Johannesburg, South Africa), Stephen Vreden (SRCS, Academic Hospital Paramaribo, Paramaribo, Suriname), Thuy Le (Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam).

The following individuals contributed to the systematic reviews and supporting evidence:

Diego H. Caceres (Mycotic Diseases Branch, United States Centers for Disease Control and Prevention, Atlanta, GA, USA - Center of Expertise in Mycology Radboudumc/CWZ. Nijmegen, The Netherlands), Marylou Murray (Cochrane Infectious Diseases Group, Department of Clinical Sciences, Liverpool School of Tropical Medicine. Liverpool, United Kingdom), Paul Garner (Cochrane Infectious Diseases Group, Department of Clinical Sciences, Liverpool School of Tropical Medicine. Liverpool, United Kingdom), Paul Hine (Cochrane Infectious Diseases Group, Department of Clinical Sciences, Liverpool School of Tropical Medicine. Liverpool, United Kingdom)

PAHO and WHO staff

Freddy Perez (WHO Regional Office for the Americas) provided overall coordination for the development of this guideline, with the support of Giovanni Ravasi (WHO Regional Office for the Americas), Ludovic Reveiz (WHO Regional Office for the Americas) and Nathan Ford (HIV Department, WHO).

Funding

The development of these guidelines was partly supported by funding to the Pan American Health Organization from the cooperative agreement with the United States Centers for Disease Control and Prevention.

© Pan American Health Organization and World Health Organization, 2020.

Sales, rights, and licensing. To purchase PAHO publications, visit http://publications.paho.org. To submit requests for commercial use and queries on rights and licensing, visit http://www.paho.org/permissions.

Third-party materials. If material that is attributed to a third party, such as tables, figures, or images, is reused from this work, it is the user’s responsibility to determine whether permission is needed for that reuse and to obtain permission from the copyright holder. The risk of claims resulting from infringement of any third-party-owned material or component from this work rests solely with the user.

Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO license (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo).

Under the terms of this license, this work may be copied, redistributed, and adapted for non-commercial purposes, provided the new work is issued using the same or equivalent Creative Commons license and it is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that the Pan American Health Organization (PAHO) and the World Health Organization (WHO) endorses any specific organization, product, or service. Use of the PAHO and WHO logo is not permitted.

Bookshelf ID: NBK587188
Contents